Context.—Percutaneous image-guided core biopsy is increasingly becoming the method of
choice to evaluate impalpable breast lesions presenting with mammographically detected …

The purpose of this study was to determine whether there is a criterion that can be utilized to
determine if excisional biopsy is indicated following the diagnosis of lobular neoplasia (LN) …

PURPOSE: To review outcomes of lesions diagnosed at core-needle breast biopsy as
atypical lobular hyperplasia (ALH) or lobular carcinoma in situ (LCIS). MATERIALS AND …

Core needle biopsy is the preferred technique for evaluating breast masses and abnormal
mammographic findings. The frequency of detection of noninvasive lobular lesions by core …

Lobular neoplasia including lobular carcinoma in situ (LCIS) and atypical lobular
hyperplasia (ALH) may be identified in breast core needle biopsies as incidental findings or …

The management of a core biopsy diagnosis of lobular neoplasia is controversial. Detailed
radiological–pathological review of 47 patients with cores showing classical lobular …

Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) diagnosed in core
needle biopsy (CNB) are generally regarded as risk indicators for developing invasive …

Lobular neoplasia (LN), including atypical lobular hyperplasia (ALH) and lobular carcinoma
in situ, may be encountered in breast core biopsies performed for mammographic …

BACKGROUND Approximately 25% of all cases of atypical ductal hyperplasia (ADH)
diagnosed on core biopsy of the breast are associated with ductal carcinoma in situ (DCIS) …

Design We evaluated all cases of ALH on core biopsy from 1999 to 2009 from our institution,
focusing on cases with≤ 3 foci of ALH (minimal), paired excision, and no other lesion on the …